PATENT CLAIM ANALYSIS

Application Number: 15778615
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2019-05
Patent Classification: ["424", "139100"]

Abstract:
A method can treat a patient suffering from at least one of fibrosis and a fibrotic disorder. The method includes administering a therapeutically effective amount of an anti-αv integrin antibody DI17E6, or a biologically active variant or modification thereof, to the patient.

Claim (Index 4):
The anti-\u03b1v integrin antibody DI17E6, or a biologically active variant or modification thereof, for use according to  claim 1 ,\n wherein said fibrotic disorder comprises or is systemic sclerosis (SSc).

Metadata:
- Claim Count in Document: 5.0
- Percentile: 93.0
- Lexical Diversity: 1.24324
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['10966845', '14390562', '15852977', '13445759', '10484329']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7022521051471482
- 35 USC 102 Novelty (BERT): 0.5225799255573035
- Combined Prediction Score: 0.6842848871881638
- Mean Citation Score: 293.606982
- Max Citation Score: 312.09485
- Similarity Product: 195.4541337264836

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test